Sight Sciences Inc reports results for the quarter ended September 30 - Earnings Summary
Sight Sciences Inc SGHT reported a quarterly adjusted loss of 22 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -27 cents. The mean expectation of seven analysts for the quarter was for a loss of 21 cents per share. Wall Street expected results to range from -31 cents to -11 cents per share.
Revenue rose 0.7% to $20.16 million from a year ago; analysts expected $20.40 million.
Sight Sciences Inc's reported EPS for the quarter was a loss of 22 cents.
The company reported a quarterly loss of $11.07 million.
Sight Sciences Inc shares had fallen by 25.7% this quarter and lost 9.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 8% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell."
The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"
Wall Street's median 12-month price target for Sight Sciences Inc is $5.50
This summary was machine generated from LSEG data November 9 at 12:28 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2024 | -0.21 | -0.22 | Missed |
Jun. 30 2024 | -0.30 | -0.25 | Beat |
Mar. 31 2024 | -0.28 | -0.33 | Missed |
Dec. 31 2023 | -0.32 | -0.22 | Beat |